Your search returned 2 results.

Results
	1.	Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence. [electronic resource] by Oliva, Esther N Lauseker, Michael Aloe Spiriti, Maria Antonietta Poloni, Antonella Cortelezzi, Agostino Palumbo, Giuseppe A Balleari, Enrico Sanpaolo, Grazia Volpe, Antonio Ricco, Alessandra Ronco, Francesca Alati, Caterina D'Errigo, Maria Grazia Santacaterina, Irene Kündgen, Andrea Germing, Ulrich Latagliata, Roberto Producer: 20161013 In: Cancer medicine vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial. [electronic resource] by Oliva, Esther N Alati, Caterina Santini, Valeria Poloni, Antonella Molteni, Alfredo Niscola, Pasquale Salvi, Flavia Sanpaolo, Grazia Balleari, Enrico Germing, Ulrich Fenaux, Pierre Stamatoullas, Aspasia Palumbo, Giuseppe A Salutari, Prassede Impera, Stefana Avanzini, Paolo Cortelezzi, Agostino Liberati, Anna Marina Carluccio, Paola Buccisano, Francesco Voso, Maria Teresa Mancini, Stefano Kulasekararaj, Austin Morabito, Fortunato Bocchia, Monica Cufari, Patrizia Spiriti, Maria Antonietta Aloe Santacaterina, Irene D'Errigo, Maria Grazia Bova, Irene Zini, Gina Latagliata, Roberto Producer: 20180209 In: The Lancet. Haematology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)